NCT03181451 - Evaluate the PK, Safety, Tolerability of Ferric Maltol at 3 Dosage Levels in Paediatric Subjects With Iron Deficiency | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 14, 2017

Primary Completion Date

March 28, 2018

Study Completion Date

March 28, 2018

Conditions

Iron Deficiency, Anaemia in ChildrenIron-Deficiency

Interventions

DRUG

Ferric Maltol

To assess the pharmacokinetics and iron uptake of Ferric Maltol through measurement of serum iron, transferrin saturation (TSAT) and plasma concentrations of maltol and maltol glucuronide.

Trial Locations (7)

LE1 5WW

Leicester Royal Infirmary, Leicester

L14 5AB

Alder Hey Children's NHS Foundation Trust, Liverpool

NW1 2PG

University College London Hospitals NHS Foundation Trust, London

SE5 9RS

King's College Hospital NHS Foundation Trust, London

WC1N 3JH

Great Ormond Street Hospital, London

M13 9WL

Royal Manchester Children's Hospital, Manchester

NG7 2UH

Nottingham University Hospital, Nottingham